vTv Therapeutics (VTVT) Institutional Ownership $20.41 +0.65 (+3.29%) Closing price 09/15/2025 03:55 PM EasternExtended Trading$20.73 +0.32 (+1.57%) As of 09/15/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for vTv Therapeutics (NASDAQ:VTVT)CurrentInstitutional OwnershipPercentage17.51%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$2.61MNumber ofInstitutional Sellers(last 12 months)0 Get VTVT Insider Trade Alerts Want to know when executives and insiders are buying or selling vTv Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data VTVT Institutional Buying and Selling by Quarter vTv Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2025Connective Capital Management LLC9,377$162K0.1%N/A0.294% 2/12/2025Geode Capital Management LLC11,634$158K0.0%+12.9%0.365% 2/12/2025JPMorgan Chase & Co.1,803$25K0.0%N/A0.057% 11/13/2024FMR LLC178,200$2.40M0.0%N/A5.920% 5/15/2024Baker BROS. Advisors LP97,314$2.29M0.0%N/A3.233% 11/8/2023Pathstone Family Office LLC242,937$116K0.0%N/A0.232% 2/9/2023HBK Sorce Advisory LLC57,694$38K0.0%N/A0.055% 8/8/2022Simon Quick Advisors LLC30,000$36K0.0%N/A0.033% 2/15/2022Samsara BioCapital LLC1,635,509$1.63M0.3%N/A1.816% 2/10/2022Rafferty Asset Management LLC69,067$69K0.0%+26.7%0.077% Get the Latest News and Ratings for VTVT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for vTv Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/2/2022Cim Investment Management Inc.354,746$447K0.1%+100.0%0.394% 11/16/2021Two Sigma Securities LLC17,087$26K0.0%N/A0.021% 11/15/2021Marshall Wace LLP23,388$36K0.0%-91.4%0.028% 11/15/2021GSA Capital Partners LLP115,472$177K0.0%N/A0.139% 11/10/2021Rafferty Asset Management LLC54,530$83K0.0%N/A0.065% 9/3/2021Parametric Portfolio Associates LLC12,444$28K0.0%-52.5%0.015% 8/25/2021Marshall Wace LLP272,255$621K0.0%+53.8%0.336% 8/17/2021Millennium Management LLC294,621$672K0.0%+2,235.9%0.363% 8/16/2021Squarepoint Ops LLC28,783$66K0.0%N/A0.035% 8/16/2021AQR Capital Management LLC52,647$120K0.0%+68.7%0.065% 8/16/2021Cubist Systematic Strategies LLC14,169$32K0.0%N/A0.017% 8/16/2021State Street Corp90,487$206K0.0%-67.5%0.112% 8/16/2021Marshall Wace LLP272,255$621K0.0%+53.8%0.336% 8/13/2021Northern Trust Corp40,577$93K0.0%-75.1%0.050% 8/13/2021Cim Investment Management Inc.177,373$404K0.1%+45.6%0.219% 8/13/2021Geode Capital Management LLC196,200$447K0.0%-26.7%0.242% 8/13/2021Vanguard Group Inc.1,758,124$4.01M0.0%+117.7%2.168% 8/12/2021XTX Topco Ltd20,045$46K0.0%+79.7%0.025% 8/12/2021Ergoteles LLC54,200$124K0.0%N/A0.067% 8/11/2021Susquehanna International Group LLP42,754$97K0.0%N/A0.053% 8/11/2021Susquehanna Fundamental Investments LLC26,765$61K0.0%-24.5%0.033% (Data available from 1/1/2016 forward) VTVT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VTVT shares? During the previous two years, the following institutional investors and hedge funds held shares of vTv Therapeutics shares: FMR LLC ($2.40M), Baker BROS. Advisors LP ($2.29M), Connective Capital Management LLC ($162K), Geode Capital Management LLC ($158K), and Pathstone Family Office LLC ($116K), JPMorgan Chase & Co. ($25K).Learn more on vTv Therapeutics' institutional investors. What percentage of vTv Therapeutics' stock is owned by institutional investors? 17.51% of vTv Therapeutics' stock is owned by institutional investors. Learn more on VTVT's institutional investor holdings. Which institutional investors have been buying vTv Therapeutics' stock? The following institutional investors have purchased vTv Therapeutics' stock in the last 24 months: Pathstone Family Office LLC ($242.94K), FMR LLC ($178.20K), Baker BROS. Advisors LP ($97.31K), Connective Capital Management LLC ($9.38K), JPMorgan Chase & Co. ($1.80K), and Geode Capital Management LLC ($1.33K). How much institutional buying is happening at vTv Therapeutics? Institutional investors have bought a total of 190,707 shares in the last 24 months. This purchase volume represents approximately $2.61M in transactions. Related Companies LYEL Major Shareholders TKNO Major Shareholders TNXP Major Shareholders SGMT Major Shareholders ACIU Major Shareholders ACRS Major Shareholders HUMA Major Shareholders AVTE Major Shareholders OGI Major Shareholders TNYA Major Shareholders This page (NASDAQ:VTVT) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored“Godfather of AI’s” dire warningAI pioneer Geoffrey Hinton warns the technology could create massive unemployment and widen inequality, but Po...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding vTv Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share vTv Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VTVT Stock Alerts